Surgery
Volume 28, Issue 3 , Pages 117-124 , March 2010

Imaging techniques in breast cancer

References 

  1. Kopans DB. Beyond randomised control trials: organised mammographic screening substantially reduces breast cancer mortality. Cancer. 2002;94:580–581
  2. Guidance on screening and symptomatic breast imaging. Royal College of Radiologists; 2003;ISBN 1 872599 850, RCR ref BFCR(03)2
  3. Fischer U, Baum F, Obenauer S, et al. Comparative study in patients with microcalcifications: full-field digital mammography vs screen-film mammography. Eur Radiol. 2002;12:2679–2683
  4. Blanks RG, Wallis MG, Moss SM. A comparison of cancer detection rates achieved by breast cancer screening programmes by number of readers, for one and two view mammography: results from the UK National Health Service breast screening programme. J Med Screen. 1998;5:195–201
  5. Birdwell RL, Ikeda DM, O'Shaughnessy KF, et al. Mammographic characteristics of 115 missed cancers later detected with screening mammography and the potential utility of computer-aided detection. Radiology. 2001;219:192–202
  6. Hong AS, Rosen EL, et al. BI-RADS for sonography: positive and negative predictive value of sonographic features. AJR. 2005;184:1260–1265
  7. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal time course data useful for differential diagnosis of enhancing lesions?. Radiology. 1999;211:101–110
  8. Gorczyca DP, Sinha S, Ahn CY, et al. Silicone breast implants in vivo: MR imaging. Radiology. 1992;185:407–410
  9. Kneeshaw PJ, Turnbull LW, Smith A, et al. Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer. Eur J Surg Oncol. 2003;29:32–37
  10. Warren RML, Bobrow LG, Earl HM, et al. Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?. Br J Cancer. 2004;90:1349–1360
  11. The classification and care of women at high risk of familial breast cancer in primary, secondary and tertiary care. an update National Institute for Health and Clinical Excellence; July 2006;CG 41
  12. Clarke D, Khonji NI, Mansel RE. Sentinel node biopsy in breast cancer: ALMANAC trial. World J Surg. 2001;25:819–822
  13. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546–553
  14. Avril N, Menzel M, Dose J, et al. Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. J Nucl Med. 2001;42:9–16

PII: S0263-9319(09)00299-3

doi: 10.1016/j.mpsur.2009.12.004

Surgery
Volume 28, Issue 3 , Pages 117-124 , March 2010

Article Tools

* Image Usage & Resolution